These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 16360897

  • 1. Use of low-molecular-weight heparins in the treatment and secondary prevention of cancer-associated thrombosis.
    Grande C, Caparro M.
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):41-9. PubMed ID: 16360897
    [Abstract] [Full Text] [Related]

  • 2. Management of thromboembolism in patients with cancer.
    Viale PH.
    Oncol Nurs Forum; 1999 Nov; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
    [Abstract] [Full Text] [Related]

  • 3. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J, Goodin S.
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [Abstract] [Full Text] [Related]

  • 4. Nursing interventions in the management of patients with cancer-associated thrombosis.
    Gillespie TW.
    Semin Oncol Nurs; 2005 Nov; 21(4 Suppl 1):50-9. PubMed ID: 16360898
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The role of low-molecular-weight heparins as supportive care therapy in cancer-associated thrombosis.
    Cunningham RS.
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S17-25; quiz S41-2. PubMed ID: 16638457
    [Abstract] [Full Text] [Related]

  • 7. Heparin and low-molecular-weight heparin therapy for venous thromboembolism. The twilight of anticoagulant monitoring.
    Hull RD, Pineo GF, Stein P.
    Int Angiol; 1998 Dec; 17(4):213-24. PubMed ID: 10204652
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of cancer-associated thrombosis: distinguishing among antithrombotic agents.
    Pruemer J.
    Semin Oncol; 2006 Apr; 33(2 Suppl 4):S26-39; quiz S41-2. PubMed ID: 16638458
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
    Rhodes S, Bond S.
    Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
    [Abstract] [Full Text] [Related]

  • 12. Low-molecular-weight heparin in outpatient treatment of DVT.
    Yeager BF, Matheny SC.
    Am Fam Physician; 1999 Feb 15; 59(4):945-52. PubMed ID: 10068716
    [Abstract] [Full Text] [Related]

  • 13. Treatment of pulmonary embolism: The use of low-molecular-weight heparin in the inpatient and outpatient settings.
    Hull RD.
    Thromb Haemost; 2008 Mar 15; 99(3):502-10. PubMed ID: 18327398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.